Videos

Nick and Jake’s Fight for Life-Changing Treatment Access

Nick and Jake both struggled to find an effective treatment to manage their obesity. Once they found a treatment that worked for them, health plans eventually stopped covering their medications. They hope that sharing their story will allow patients to access the innovative treatments they need.

Why Obesity Treatment Access Matters: Sarah’s Story

Sarah Baker found a treatment that helped manage her obesity, but insurance barriers prevented her from accessing the life-changing treatment she needed. In her testimonial, she encouraged policymakers to support the Treat and Reduce Obesity Act.

John Woods’ Journey With Resistant Hypertension

John Woods, a renowned chef from Mississippi, dealt with sudden and recurrent hypertensive crises. When his doctor told him about renal denervation, he was finally able to manage his condition.

Cardiologists Tell CMS: Measure What Matters

71 million American adults have high cholesterol, which is a key risk factor for heart attacks. Despite advances in medicine, this number isn’t going down. That’s because current U.S. guidelines do not measure toward a cholesterol goal. That needs to change.

Measure What Matters: LDL Cholesterol

71 million American adults have high cholesterol, which is a key risk factor for heart attacks. Despite advances in medicine, this number isn’t going down. That’s because current U.S. guidelines do not measure toward a cholesterol goal. That needs to change.

Heart Attack at 28: Tatum’s Story

Tatum Cushing suffered a heart attack at 28. To ensure patients like Tatum have access to the transformative therapies they need to manage chronic conditions, Congress must pass the MINI Act.

How Genetically Targeted Technologies Changed Ozzie’s Life

Patient advocate Ozzie Giglio was diagnosed with cardiac amyloidosis, a rare disease that causes the heart muscles to stiffen. But thanks to new advances in genetically targeted technologies, Ozzie can live a longer, healthier life.

A MINI Act Could Be Big for Heart Patients

The MINI Act would allow more time for research, investment and infrastructure in the development of novel therapies like genetically targeted technologies for heart patients.